Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol 25 vs 50 mcg for labor induction in obese pregnant women
IRCT20230611058454N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of misoprostol in induced labor (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Time from induction to delivery. Started Jan 2025; status: completed.
02
Drugs
misoprostol
03
Conditions
induced labor
Beyond the preview
Go deeper on IRCT20230611058454N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230611058454N2.